World's Best Scientists 2026 revealed!

D-Index & Metrics

Chemistry

D-Index
65
Citations
15024
World Ranking
7664
National Ranking
2244

Joshua Rokach publication distribution in Chemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Chemistry in 2026. The highlighted bar marks where Joshua Rokach sits on this spectrum.

61–80 publications: 66 scientists 81–100 publications: 302 scientists 101–120 publications: 623 scientists 121–140 publications: 918 scientists 141–160 publications: 1,218 scientists 161–180 publications: 1,350 scientists 181–200 publications: 1,344 scientists 201–220 publications: 1,281 scientists 221–240 publications: 1,216 scientists 241–260 publications: 1,100 scientists 261–280 publications: 979 scientists 281–300 publications: 939 scientists 301–320 publications: 764 scientists 321–340 publications: 643 scientists 341–360 publications: 628 scientists 361–380 publications: 522 scientists 381–400 publications: 459 scientists 401–420 publications: 397 scientists 421–440 publications: 327 scientists 441–460 publications: 270 scientists 461–480 publications: 265 scientists 481–500 publications: 252 scientists 501–520 publications: 201 scientists 521–540 publications: 185 scientists 541–560 publications: 148 scientists 561–580 publications: 148 scientists 581–600 publications: 132 scientists 601–620 publications: 114 scientists 621–640 publications: 104 scientists 641–660 publications: 91 scientists 661–680 publications: 92 scientists 681–700 publications: 73 scientists 701–720 publications: 57 scientists 721–740 publications: 54 scientists 741–760 publications: 67 scientists 761–780 publications: 45 scientists 781–800 publications: 46 scientists 801–820 publications: 39 scientists 821–840 publications: 32 scientists 841–860 publications: 36 scientists 861–880 publications: 29 scientists 881–900 publications: 26 scientists 901–920 publications: 24 scientists 921–940 publications: 14 scientists 941–960 publications: 23 scientists 961–980 publications: 28 scientists 981–1,000 publications: 15 scientists 1,001–1,020 publications: 29 scientists 1,021–1,040 publications: 12 scientists 1,041–1,060 publications: 19 scientists 1,061–1,080 publications: 12 scientists 1,081–1,100 publications: 6 scientists 1,101–1,120 publications: 8 scientists 1,121–1,140 publications: 12 scientists 1,141–1,160 publications: 5 scientists 1,161–1,180 publications: 6 scientists 1,181–1,200 publications: 14 scientists 1,201–1,220 publications: 7 scientists 1,221–1,240 publications: 2 scientists 1,241–1,260 publications: 6 scientists 1,261–1,280 publications: 4 scientists 1,281–1,294 publications: 6 scientists 1,295+ publications: 100 scientists
61 publications 1,295+

This scientist: 349 publications — 73rd percentile

73% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,295 publications or more.

Joshua Rokach D-index placement in Chemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Chemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Joshua Rokach sits on this spectrum.

40–41 D-Index: 289 scientists 42–43 D-Index: 612 scientists 44–45 D-Index: 808 scientists 46–47 D-Index: 776 scientists 48–49 D-Index: 835 scientists 50–51 D-Index: 861 scientists 52–53 D-Index: 872 scientists 54–55 D-Index: 933 scientists 56–57 D-Index: 1,051 scientists 58–59 D-Index: 930 scientists 60–61 D-Index: 882 scientists 62–63 D-Index: 834 scientists 64–65 D-Index: 731 scientists 66–67 D-Index: 775 scientists 68–69 D-Index: 683 scientists 70–71 D-Index: 646 scientists 72–73 D-Index: 561 scientists 74–75 D-Index: 501 scientists 76–77 D-Index: 437 scientists 78–79 D-Index: 388 scientists 80–81 D-Index: 354 scientists 82–83 D-Index: 292 scientists 84–85 D-Index: 275 scientists 86–87 D-Index: 254 scientists 88–89 D-Index: 235 scientists 90–91 D-Index: 185 scientists 92–93 D-Index: 192 scientists 94–95 D-Index: 155 scientists 96–97 D-Index: 163 scientists 98–99 D-Index: 125 scientists 100–101 D-Index: 105 scientists 102–103 D-Index: 105 scientists 104–105 D-Index: 112 scientists 106–107 D-Index: 88 scientists 108–109 D-Index: 68 scientists 110–111 D-Index: 69 scientists 112–113 D-Index: 65 scientists 114–115 D-Index: 79 scientists 116–117 D-Index: 61 scientists 118–119 D-Index: 44 scientists 120–121 D-Index: 37 scientists 122–123 D-Index: 40 scientists 124–125 D-Index: 33 scientists 126–127 D-Index: 26 scientists 128–129 D-Index: 34 scientists 130–131 D-Index: 35 scientists 132–133 D-Index: 25 scientists 134–135 D-Index: 27 scientists 136–137 D-Index: 17 scientists 138–139 D-Index: 16 scientists 140–141 D-Index: 20 scientists 142–143 D-Index: 20 scientists 144–145 D-Index: 15 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 9 scientists 150–151 D-Index: 16 scientists 152–153 D-Index: 11 scientists 154–155 D-Index: 9 scientists 156–157 D-Index: 3 scientists 158 D-Index: 3 scientists 159+ D-Index: 98 scientists
40 D-Index 159+

This scientist: 65 D-Index — 58th percentile

58% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 159 D-Index or more.

Research.com Recognitions

  • 2018 - Fellow, National Academy of Inventors

Overview

Joshua Rokach is affiliated with the Florida Institute of Technology in the United States. Their research predominantly focuses on Medicine, Immunology and Microbiology, and Biochemistry, Genetics and Molecular Biology. Within these broad fields, their work concentrates on subfields including Physiology, Biochemistry, Immunology, Microbiology, and Organic Chemistry.

The main topics in Rokach's research encompass asthma and respiratory diseases, eicosanoids and hypertension pharmacology, mast cells and histamine, antimicrobial peptides and activities, pediatric health and respiratory diseases, immune cell function and interaction, and neuropeptides and animal physiology.

Rokach has contributed to several recent scholarly papers, including:

  • "Targeting the OXE receptor as a potential novel therapy for asthma" (2020), published in Biochemical Pharmacology
  • "Targeting the OXE receptor with a selective antagonist inhibits allergen-induced pulmonary inflammation in non-human primates" (2021), published in British Journal of Pharmacology
  • "Metabolism of anti-inflammatory OXE (oxoeicosanoid) receptor antagonists by nonhuman primates" (2022), published in European Journal of Pharmaceutical Sciences
  • "Leukotriene receptors (version 2020.3) in the IUPHAR/BPS Guide to Pharmacology Database" (2020), published in IUPHAR/BPS Guide to Pharmacology CITE
  • "Leukotriene receptors in GtoPdb v.2023.1" (2023), published in IUPHAR/BPS Guide to Pharmacology CITE

Frequent co-authors in Rokach's work include William S. Powell, Qiuji Ye, Shishir Chourey, Chintam Nagendra Reddy, and Magnus Bäck.

Their publications frequently appear in venues such as IUPHAR/BPS Guide to Pharmacology CITE, Biochemical Pharmacology, British Journal of Pharmacology, European Journal of Pharmaceutical Sciences, and Chemical and Pharmaceutical Bulletin.

In recognition of their contributions, Joshua Rokach was named a Fellow of the National Academy of Inventors in 2018.

Best Publications

  • Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in ApoE-deficient mice.

    Domenico Praticò;Rajendra K. Tangirala;Daniel J. Rader;Joshua Rokach

  • Isoprostanes: formation, analysis and use as indices of lipid peroxidation in vivo.

    John A. Lawson;Joshua Rokach;Garret A. FitzGerald

  • Prostaglandin D2 is a potent chemoattractant for human eosinophils that acts via a novel DP receptor

    Guillaume Monneret;Sylvie Gravel;Michael Diamond;Joshua Rokach

  • Biosynthesis, biological effects, and receptors of hydroxyeicosatetraenoic acids (HETEs) and oxoeicosatetraenoic acids (oxo-ETEs) derived from arachidonic acid.

    William S. Powell;Joshua Rokach

  • Effects of vitamin E on lipid peroxidation in healthy persons.

    Emma A. Meagher;Orla P. Barry;John A. Lawson;Joshua Rokach

  • Pharmacology of L-660,711 (MK-571): a novel potent and selective leukotriene D4 receptor antagonist.

    T. R. Jones;R. Zamboni;M. Belley;E. Champion

  • ALCOHOL-INDUCED GENERATION OF LIPID PEROXIDATION PRODUCTS IN HUMANS

    Emma A. Meagher;Orla P. Barry;Anne Burke;Michael R. Lucey

  • Arachidonic acid metabolism in purified human lung mast cells.

    S P Peters;D W MacGlashan;E S Schulman;R P Schleimer

  • Regioselective synthesis of acylpyrroles

    Masatoshi Kakushima;Pierre Hamel;Richard Frenette;Joshua Rokach

  • Measuring leukotrienes of slow reacting substance of anaphylaxis: development of a specific radioimmunoassay.

    E C Hayes;D L Lombardo;Y Girard;A L Maycock

  • IPF2α-I: An index of lipid peroxidation in humans

    Domenico Praticò;Orla P. Barry;John A. Lawson;Mustafa Adiyaman

  • THE ISOPROSTANES IN BIOLOGY AND MEDICINE

    Domenico Praticò;John A. Lawson;Joshua Rokach;Garret A. FitzGerald

  • Quantitative high performance liquid chromatography/tandem mass spectrometric analysis of the four classes of F2-isoprostanes in human urine

    Hongwei Li;John A. Lawson;Muredach Reilly;Mustafa Adiyaman

  • Vitamin E reduces amyloidosis and improves cognitive function in Tg2576 mice following repetitive concussive brain injury

    Valeria Conte;Kunihiro Uryu;Scott Fujimoto;Scott Fujimoto;Yuemang Yao

  • NOMENCLATURE OF ISOPROSTANES : A PROPOSAL

    J Rokach;S.P Khanapure;S.-W Hwang;M Adiyaman

  • Biochemistry, biology and chemistry of the 5-lipoxygenase product 5-oxo-ETE.

    William S Powell;Joshua Rokach

  • Analysis of leukotrienes by high-pressure liquid chromatography

    W.Rodney Mathews;Joshua Rokach;Robert C. Murphy

  • 15-Deoxy-delta 12,14-prostaglandins D2 and J2 are potent activators of human eosinophils.

    Guillaume Monneret;Hongping Li;Julian Vasilescu;Joshua Rokach

  • The Isoprostanes: A Perspective

    J. Rokach;S.P. Khanapure;S.-W. Hwang;M. Adiyaman

  • F2-isoprostanes as indices of lipid peroxidation in inflammatory diseases.

    Domenico Praticò;Joshua Rokach;John Lawson;Garret A. FitzGerald

  • Chronic melatonin therapy fails to alter amyloid burden or oxidative damage in old Tg2576 mice: implications for clinical trials.

    Joseph Quinn;Doris Kulhanek;Jessica Nowlin;Richard Jones

Frequent Co-Authors

William S. Powell
William S. Powell McGill University Health Centre
Garret A. FitzGerald
Garret A. FitzGerald University of Pennsylvania
Domenico Praticò
Domenico Praticò Temple University
Robert N. Young
Robert N. Young Simon Fraser University
Robert Zamboni
Robert Zamboni MSD (United States)
Anthony W. Ford-Hutchinson
Anthony W. Ford-Hutchinson Independent Scientist / Consultant, US
Shozo Yamamoto
Shozo Yamamoto Kyoto Women's University
Natsuo Ueda
Natsuo Ueda Kagawa University
Alan R. Brash
Alan R. Brash Vanderbilt University
Virginia M.-Y. Lee
Virginia M.-Y. Lee University of Pennsylvania

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Chemistry as a major in the USA opens doors to varied career paths, but it’s also important to consider interdisciplinary opportunities. For instance, students interested in the legal aspects related to scientific research might explore paralegal degree programs. These can complement a chemistry background by providing skills in regulatory compliance and intellectual property law.

If your interest lies more in public safety or forensic science, pathways connected to criminal justice are worth investigating. Many students start with some of the best online associate degree programs in criminal justice to gain foundational knowledge that can be paired with scientific expertise.

Considering the cost aspect is crucial too. Understanding criminal justice degree tuition details can help you plan financially if you decide to pursue dual degrees or complementary online courses.

Alternatively, a Chemistry degree can lead to careers in the pharmaceutical industry, where roles like pharmaceutical sales representatives are in demand. Learning about the pharmaceutical rep salary and career pathways can provide insight into this lucrative option.

Best Scientists Citing Joshua Rokach

Trending Scientists

Recently Published Articles